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Summary: This paper describes a rapid and efficient method for the sorting of in vitro activated cytolytic 
effectors cells. For cytotoxic assays, a large number of cells with conserved function must be rapidly obtained. 
Immunomagnetic sorting was chosen because it is faster than flow cytometry sorting. The MACS system 
requires the use of paramagnetic beads of small diameter (100-150 nm), reputed to interfere minimally with cell 
function. In order to generate the cytolytic effectors, peripheral blood lymphocytes were cultivated in the 
presence of interleukin-2 (50 U/ml) and anti-CD3 monoclonal antibody (BMA030, 100 ng/ml) for 4 days. Cell 
separation was based on the membrane expression of the CD3 complex. The purity obtained for positive (CD3+) 
cell sorting with the MACS was higher than 95 %. The purity of negative (CD3-) cell fraction was more variable, 
but further purification by flow cytometry rapidly yielded purity higher than 95 %. Cytotoxic assays were 
performed against four target cell lines (K562, Daudi, HL60 and U937) and proliferation assays showed that 
both negatively and positively selected populations had conserved their function acquired during culture in the 
presence of anti-CD3 mAb and IL2. 
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Immunosélection de cellules effectrices cytolytiques triées par champ magnétique (MACS) 
Résumé: Cet article décrit une méthode de tri cellulaire rapide et efficace permettant de séparer des cellules 
effectrices cytotoxiques activées in vitro. Nous avons choisi le tri par champ magnétique car les tests de 
cytotoxicité à médiation cellulaire requièrent un grand nombre de cellules ayant conservé leurs fonctions. De 
plus, le système MACS utilise des billes paramagnétiques de petite taille (100-150 nm de diamètre) afin de 
n'interférer que faiblement avec les fonctions cellulaires. Les effecteurs cytolytiques sont obtenus à partir de 
lymphocytes du sang périphérique cultivés en présence d'un anticorps monoclonal anti-CD3 (100 ng/ml) et 
d'interleukine-2 (50 U/ml) durant 4 jours. La séparation des cellules est basée sur l'expression membranaire du 
complexe CD3. La pureté obtenue pour les cellules positives (CD3+) triées est égale ou supérieure à 95 %. Par 
contre, la pureté de la fraction cellulaire négative (CD3-) est plus variable, mais une séparation consécutive de 
cette population par cytométrie en flux permet d'atteindre rapidement une pureté supérieure à 95 %. Les tests 
cytotoxiques réalisés contre 4 lignées de cellules tumorales (K562, Daudi, HL60 et U937) ainsi que les tests de 
prolifération montrent que les populations sélectionnées négativement et positivement ont conservé leur 
fonction. 
Mots-clés: Lymphocyte, Cytométrie magnétique, CD3, Cytotoxicité; Epreuve, Cellules effectrices. 
 
BSA      =   bovine serum albumin.                                                 mAb      =   monoclonal antibody. 
CPM     =   counts per minute.                                                        NK        =   natural killer. 
FACS    =   fluorescence-activated cell sorter.                               PBL      =   peripheral blood lymphocyte. 
FCS       =   foetal calf serum.                                                         PBS       =   phosphate-buffered saline. 
FITC     =   fluorescein isothiocyanate.                                           PE         =   phycoerythrin. 
IL2        =   interleukin-2.                                                                PHA      =   phytohaemagglutinin. 
LAK      =   lymphokine-activated killer.                                         rIL2       =   recombinant IL2. 
MACS   =   magnetic cell sorter. 
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INTRODUCTION 
In vitro stimulation of human peripheral blood lymphocytes (PBL) by antibodies directed against the TcR-CD3 
complex and by interleukin-2 (IL2) generates non-specific cytotoxic activity against various tumour cell lines 
(Ochoa et al., 1987 ; Nishimura et al., 1992). The nature of these cytolytic effectors is likely to be heterogeneous 
since, in addition to T lymphocytes, bystander cells can be activated by cytokines released by stimulated T cells. 
Given the potential differences in killing and target cell recognition mechanisms, there would be considerable 
interest in evaluating the activity of each cell subset individually. 
Such an approach implies the use of efficient cell selection techniques which fulfill the following requirements : 
(1) the purity in positive and negative fractions should be high enough (i.e. > 95 %) to enable accurate analysis 
of selected cell subsets in the absence of any significant contamination; (2) the technique of selection should not 
interfere with cell function (the duration of the selection procedures is a critical aspect of this problem) and (3) 
the yield of sorting techniques should be optimal to ensure recovery of large numbers of cells (i.e. > 0.5 × 106 
cells) in a limited period of time. These aspects are crucial for the realization of functional experiments such as 
4-h chromium release assays. 
The flow cell sorting techniques ensure very high purity (95-99 %). However, the sort is based on cell-by-cell 
processing and is consequently a long time process which currently lasts several hours (Lindmo et al., 1990). On 
the contrary, the duration of immunomagnetic selection does not depend on the total number of cells to sort. This 
is a major concern when several million purified cells are needed for functional assays. Among the 
immunoselection techniques commercially available (Lea et al., 1985; Gee et al., 1991; Naume et al., 1991), the 
MACS system (Miltenyi et al., 1990) was chosen because the small size of the magnetic beads (100-150 nm 
diameter) apparently does not significantly interfere with cell function even in the positively sorted fraction 
(Pflueger et al., 1990). 
This study was designed to determine whether immunoselection with MACS is a practical tool for dissection of 
the respective participation of cytolytic subsets, particularly CD3+ T cells and non T cells, in lymphocyte 
populations activated in vitro. MACS selection established that both T lymphocytes and NK cells are involved in 
cytolytic activity generated by stimulation with an anti-CD3 monoclonal antibody (mAb) and interleukin-2 
(IL2). 
 
MATERIALS AND METHODS 
Antibodies 
Biotinylated mAb directed against human CD3 were purchased from Immunotech (Marseille, France). 
Streptavidin-FITC was obtained from Boehringer Mannheim (Brussels, Belgium). The antibodies used for 
immunofluorescence assays are listed in table I. 
Preparation and culture of PBL 
Fresh heparinized blood from healthy donors (Centre de transfusion de Liège) was diluted 1:2 with RPMI-1640 
(Gibco BRL, Gent, Belgium), layered over "Lymphoprep" (Nycomed; Oslo, Norway) and spun at 400 g for 30 
min. The mononuclear cells at the interface were harvested, washed three times and counted. Culture medium 
consisted of RPMI-1640 supplemented with 1 % non-essential amino acids (Gibco), sodium pyruvate (1 mM 
Gibco), 30 U/ml penicillin-streptomycin (Gibco) (completed medium) and 5 % pooled heat-inactivated human 
AB serum. Cells were cultivated (1.25 × 106 cells/ml) in 25-cm2 tissue culture flasks (Falcon, Becton Dickinson) 
in the presence of 100 ng/ml of anti-CD3 mAb (BMA030, IgG2a, Behringwerke, Marburg, Germany) and 50 
U/ml of human rIL2 kindly provided by Glaxo Institute for Molecular Biology (AG, Genève, Switzerland). 
Cultures were incubated at 37°C in a humidified atmosphere of 5 % CO2 for 4 days. 
Cell lines 
K562 is an MHC-negative erythroleukaemic cell line commonly used to study NK activity (Lozzio and Lozzio, 
1975). The U937 cell line is derived from a histiocytic lymphoma (Sundström and Nilsson, 1976) and is NK-
sensitive. The Daudi cell line derives from a Burkitt lymphoma (Klein et al., 1968). HL60 is a promyelocytic 
leukaemia cell line (Collins et al., 1977). Both Daudi and HL60 cell lines are NK-resistant. The four cell lines 
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were cultivated in RPMI-1640 supplemented with 10 % foetal calf serum (FCS) (Gibco). i 
Magnetic cell separation 
A three-step procedure for labelling cells with biotinylated superparamagnetic beads (polysaccharide-
stabilized/iron complexes, size 100-150 nm, Bee-ton Dickinson) was used. First, the cells were stained in PBS 
(Gibco) with biotinylated anti-CD3 mAb, anti-Leu-4 (Becton Dickinson) for fresh PBL and IOT3 (Dako) for 
activated cells at a concentration of 10 µg/106 cells for 20 min. The cells were washed in PBS/EDTA (5 mM, 
Merck, Darmstadt, Germany) and incubated with streptavidin-FITC at a concentration of 10 µg/106 cells for 20 
min. After a washing step, the cells suspended in PBS/EDTA were incubated in the presence of 100 µl of 1:100 
diluted biotinylated magnetic beads for 5 min. The cells were washed in PBS/EDTA supplemented with 1 % 
bovine serum albumin (PBS/BSA, Boehringer) and 20-80 × 106 cells were suspended in a volume of 0.5-1 ml of 
PBS/BSA. All procedures were performed on ice. The MACS instrument (Becton Dickinson) is constituted 
principally by a permanent magnet of 0.6 Tesla in which is inserted a column filled with steel wool (Miltenyi et 
al., 1990). The cell suspension was applied to a precooled (4°C) separation column saturated in PBS/BSA, and 
placed in the magnetic field of the permanent magnet. Unlabelled cells were not retained in the column and were 
collected in a total volume of 3-8 ml of PBS/BSA. After washing of the column with 3-8 ml of PBS/BSA, the 
positively stained cells were eluted from the separation column outside the magnetic field with 5-15 ml in the 
syringe under gentle pressure. The cells were numerated and the viability was estimated by trypan blue exclusion 
or propidium iodide staining (Horan and Kappler, 1977). The purity of the positive and negative cell fractions 
was checked by flow cytometry (FACScan, Becton Dickinson). When needed, further purification was 
performed by flow cytometry (FACS IV, Becton Dickinson). The conditions of FACS cell sorting to achieve 95-
99 % purity were as follows: rate = 1500 cells/s, deflected drops = 3, nozzle tip = 70 µm drop generation 
frequency = 29500 Hz, drop delay = 13. 
The recovery of the sort for each subset was calculated according to the following formula: 
 
where fs is the frequency of the considered cell subset in the sorted fraction, Ns the total number of cells 
obtained after sorting, ft the frequency of this subset in the starting, unsorted population and Nt the total number 
of cells in the starting population. 
 
Table I: mAb used in immunofluorescence experiments. 
CD designation Fluorochrome conjugate mAb Company 
CD3 FITC IOT3 Dako 
CD2 FITC T11 Dako 
CD4 FITC(PE) IOT4(CD4) Immunotech (Dako) 
CD8 PE IOT8 Immunotech 
CD16 PE Leu-11c Becton-Dickinson 
CD56 PE Leu-19 Becton-Dickinson 
CD57 FITC Leu-7 Becton-Dickinson 
CD20 PE Leu-16 Becton-Dickinson 
CD19 PE IOB4 Immunotech 
CD14/CD45 PE/FITC Leucogate Becton-Dickinson 
CD25 PE CD25 Dako 
TcRαβ FITC WT31 Becton-Dickinson 
TcRγδ FITC TCRγδ Becton-Dickinson 
The mAb were purchased from Dako (Glostrup, Denmark), Immunotech and Becton-Dickinson (Erembodegem, Belgium). 
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Immunofluorescence and flow cytometry 
After separation, about 0.5 × 106 unseparated and selected cells were incubated on ice in a volume of 25 µl with 
antibodies defined in table I. After washing, cells were analysed for fluorescence intensity on a "FACScan" 
(Becton Dickinson). Double-staining was performed on unseparated and negatively selected cells. 
Cytotoxicity assays 
Effector cell populations were washed once in RPMI-1640 medium, counted and then suspended in RPMI-1640-
completed medium (10 % FCS) at a concentration of 2 × 104 cells/100 µl. Six serial dilutions were made in 96-
well U-bottom plates (Nunc). Target cells were incubated with Na51CrO4 (Medgenix, Fleurus, Belgium) for 1 h 
at 37°C (100 µCi for 1 × 106 cells in 155 µl), washed three times, counted and adjusted to obtain 5,000 cells/100 
µl. This suspension was added to the 100-µl serial dilutions of effectors cells. After centrifugation, the trays were 
incubated for 4 h at 37°C; 100 µl of supernatant were then recovered from each well and radioactivity was 
measured in a γ-counter (Cobra auto-gamma Packard, Downers Grove, IL). Maximal chromium release was 
obtained by adding 100 µl of detergent (RBS 10 % Chemical products) to 100 µl of target cells suspension and 
spontaneous release was given by incubation of target cells without effectors cells. Percent cytotoxicity was 
calculated according to the following formula: 
 
Proliferation assays 
Unsorted and sorted cells were plated in triplicate in 96-well U-bottomed plates at 104 cells per well in 200 µl of 
medium alone, in the presence of IL2 (50 U/ml) or PHA (1 %) (Difco, Detroit, Michigan). After 24 h, 0.4 µCi of 
3H-thymidine (Dupont NEN, Dreieich, Germany) was added in 25 µl of RPMI-1640. Cells were harvested with a 
cell harvester (Skatron, Lier, Norway) on glass fiber filters after 4 h and 3H-thymidine incorporation was 
determined by scintillation counting (1500 Tri Carb Packard). 
Statistical analysis 
The data were analysed using the Student's t test (StatWork, Cricket software). 
 
RESULTS 
Selection with MACS enables optimal recovery of cells with conserved viability 
Preliminary assays were performed with fresh unstimulated PBL in order to assess recovery and viability after 
MACS selection. Mean recovery of CD3+ cells reached 79.5 % ± 4 % (n = 7) in positive cell fractions ; the 
percentage of CD3+ cells lost in the negative cell fraction and in the wash was always less than 5 % (fig. 1). 
The recovery calculated for PBL activated with anti-CD3 mAb (BMA030, 100 ng/ml) and rIL2 (50 U/ml) was 
66 % ± 15 % for CD3+ cells and 64 % ± 20.5 % for CD3- cells (n = 4) (table II). 
Trypan blue and propidium iodide exclusion assays did not reveal any significant increase in cell death after 
magnetic selection (data not shown). 
MACS sorting enables purification of CD3+ T cells without significant contamination and dramatically 
enriches NK cells in the negative fraction 
After culture in the presence of anti-CD3 mAb and rIL2, 84 % ± 5 % (n = 12) of the lymphocytes expressed the 
CD3 complex (fig. 2A). After magnetic selection, the purity of CD3+ and CD3- fractions was assessed by flow 
cytometry. No additional staining step was required, since streptavidin-FITC had been used to bind the 
biotinylated magnetic beads to the biotinylated anti-CD3 mAb prior to separation. Purity of the positively sorted 
cell population was always greater than 95 % (97 % ± 1.5 % ; n = 12) (fig. 2B1). Purity of the CD3- cell fraction 
was often satisfactory (fig. 2B2), but displayed a higher variability between experiments, ranging from 50 to 
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98%. Consequently, further purification of the CD3- fraction by FACS was realized immediately after magnetic 
selection if 95 % purity was not obtained. Combined MACS + FACS purification of the CD3- fraction led to 
optimal purity, with a cell yield superior to FACS selection alone (data not shown). 
 
Fig. 1: Recovery of CD3+ cells after selection by MACS. Percentages of CD3 + cells are given for the different fractions of the 
sort. Values represent means ± SD of 7 experiments. 
 
 
Table II: Recovery of activated cells after sorting. 
 % of recovery CD3- cells in 
negative fraction 
% of recovery of CD3+ cells in 
positive fraction 
1st separation 80 46 
2nd separation 60 65 
3rd separation 36 72 
4th separation 79 82 
Mean ± SD 64 ± 20.5 66 ±15 
 
To further confirm the purity of MACS sorting by an additional staining step independent of magnetic selection, 
a panel of mAb was used to determine cell surface phenotype in unseparated and purified CD3- and CD3+ cell 
fractions. Most cells cultivated in the presence of rIL2 + anti-CD3 mAb and unsorted (table III) were T 
lymphocytes bearing the TcR α/β, whereas a minority of cells expressed the TcR γ/δ. The CD4/CD8 ratio after 4 
days of culture was unchanged compared to fresh PBL. Few cells (< 6 %) expressed NK markers (CD16, CD56, 
CD57). In the CD3-  cell fraction obtained by combined MACS + FACS purification (table III), the majority of 
the cells in this fraction expressed at least one NK cell marker. Dual-color analysis revealed that a significant 
proportion of the cells bearing NK markers were weakly positive for CD8 (CD8dim). It is noteworthy that 
lymphocytes with a high expression of CD8 (CD8hi) could not be found in the negative fraction, and 
contamination by CD4+ cells was always less than 5 %. B lymphocytes identified by CD19 represented 27 % of 
the cells in the CD3- fraction. In the CD3+ fraction (table III), T cells expressed either CD4 or CD8 on their 
surface. Few or no cells displayed the CD16, CD56 or CD20 molecules. 
Expression of the low affinity IL2 receptor (CD25) was studied in order to estimate the activation of the 
lymphocytes. In the unsorted population, CD25 was found on a large proportion of lymphocytes (67 %) (table 
III). In the CD3+ cell fraction, a similar number of cells with low affinity receptors for IL2 (71 %) were 
observed. On the other hand, only 38 % of the lymphocytes in the CD3- fraction were found to be positive for 
CD25. 
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Fig. 2: FACS analysis of CD3 expression before and after MACS purification of CD3+ and CD3- fractions. 
Fluorescence 1 (FITC) histograms are shown for one representative experiment. After sorting, an aliquot of both positive and negative cell 
populations was taken and analysed by flow cytometry. The x axis represents the fluorescence of FITC-conjugated anti-CD3 mAb and the y 
axis represents relative cell number of unseparated cells (85 % of CD3+ cells) (A), the CD3+ cell fraction (99 % purity) (B1), the CD3- cell 
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Table III: Cell surface phenotype of unseparated and purified cell fractions after in vitro activation. 
CD designation Unsorted cells % of cells ± 
SD 
CD3- cell fraction % of cells 
± SD 
CD3+ cell fraction % of 
cells ±SD 
CD3 84 ± 5 1.5±1 97.5 ±1.5 
TcR αβ 82.5 ± 6.5 ND ND 
TcR γδ 3.5±2 ND ND 
CD2 88±7.5 45 ±6.5 ND 
CD4 64.5 ±9.5 3.5 ±1 67±4 
CD8 30 ±9.5 30.5 ±4.5 31±4 
CD16 3.5±2 31±4 < 1 
CD56 6±2 49±9 2±1 
CD57 5.5±1 27 ±8 ND 
CD25 67 ±16.5 38±5 71±1.5 
CD19 ND 27 ±5.5 ND 
CD20 8±4 ND ≤ 1.5 
CD45 98.5 ±1 98 ±1 ND 
CD14 0.5 ±0.5 0.5±0.5 ND 
After 4 days of culture in the presence of anti-CD3 mAb + rIL2, cells were sorted with MACS alone for the CD3+ cell fraction and with 
MACS + FACS for the CD3- cell fraction when purity did not attain 95 %. Double staining was performed on unseparated and CD3- cell 
fractions. ND = not done. 
 
Fig. 3: Cytotoxic activity by unsorted and purified CD3+ and CD3- fractions. Specific lysis determined in a 4-h chromium 
release assay are shown for an effector : target cell ratio of 20:1 against K562 cell line (A), Daudi (B), U937 (C) and HL60 (D). Means ± SD 
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MACS purification does not interfere with cytotoxic activity or anti-CD3-induced proliferation 
Cytolytic activity of unseparated and sorted cells was measured in a 4-h chromium release assay against K562, 
Daudi, U937 and HL60 target cell lines. The stimulation with the anti-CD3 mAb and rIL2 induced a highly 
significant (p < 0.05) activity against all target cell lines (fig. 3). Depletion of CD3+ T cells was associated with 
enrichment of the cytolytic activity against K562 and Daudi cell targets (fig. 3 A and B). Accordingly, CD3+ 
cells did not show any significant lysis of these targets. On the other hand, depletion of T cells did not modify 
the activity detected against U937 and HL60 cell targets which were lysed similarly by effector cells from CD3+ 
and CD3- purification fractions (fig. 3C and 3D). This unmodified activity against U937 and HL60 target cells 
suggested that the weak cytolytic activity displayed by activated T cells against K562 and Daudi cell targets was 
not an artefact due to a functional inhibition by MACS selection. 
As controls, we looked at the possible functional interferences of the MACS system due to non-specific factors 
independent of the antibody used for selection. The passage of unstimulated cells, prepared in the absence of 
antibodies, through the separation column did not modify the level of spontaneous DNA synthesis (fig. 4), 
indicating that the MACS isolation procedure does not in itself induce cell activation. Furthermore, the 
proliferative response of these cells to PHA was not increased by the MACS procedure (fig. 4). 
The influence of MACS purification on proliferative responses were also studied at the effector stage. When 
PBL were activated for 4 days with anti-CD3 + rIL2, the isolation procedure purification with MACS did not 
modify DNA synthesis in the 24-h period after the sort (fig. 5). Finally, the specific influence of the isolation 
process on cytolytic activity at the effector stage was studied on IL2-activated lymphocytes. Neither the passage 
through the column nor the presence of the beads throughout the cytolytic assay modified the lysis of K562 by 
IL2-activated lymphocytes (data not shown). 
 
DISCUSSION 
In the present report, the MACS system proved to be an efficient technique for obtaining highly purified CD3+ T 
lymphocytes by positive selection from a heterogeneous population of PBL activated in vitro with anti-CD3 
mAb + rIL2. Negative selection of CD3- cells from the same population did not lead to similar purity, although 
values higher than 95 % were observed in some experiments. This difference between the efficiency of positive 
versus negative selection is likely to be due to the model itself rather than to intrinsic characteristics of the 
MACS system. Since CD3- lymphocytes only represented a minor cell subset in our model of activation, their 
negative purification by one cycle of MACS may have been hampered by the large proportion of CD3+ T cells. 
Furthermore, we observed that after culture in the presence of anti-CD3 mAb, the density of membrane 
expression of CD3 by T cells was heterogeneous, suggesting different kinetics of modulation or reexpression of 
the TcR-CD3 complex. Therefore, T cells expressing a low density of CD3 complexes could have bound a 
number of beads insufficient to be retained in the positive fraction. These cells could have consequently 
contaminated the negative fraction. Interestingly, when fresh or rIL2-activated PBL were studied, the expression 
of CD3 was found to be homogeneous, and negative selection of CD3-cells was constantly more efficient than 
after culture with anti-CD3 mAb + rIL2 (unpublished results). Accordingly, Abts et al. (1989), working on 
MACS purification of fresh human PBL, reported purities higher than 98 % after negative selection of CD3- 
lymphocytes. Similar results were observed by Schmitz and Radbruch (1989) using MACS negative selection of 
Thy-1 lymphocytes in a murine model. Since most contaminating CD3+ cells in our experiments expressed a low 
density of this marker, another sorting system based on the quantitative expression of the molecule (FACS) was 
chosen to improve the purity rather than several sequential runs of MACS sorting. 
The heterogeneous density of CD3 expression after anti-CD3 mAb activation suggested that some T 
lymphocytes could present a CD3-phenotype. In order to rule out contamination of the CD3- fraction by T 
lymphocytes with no membrane expression of the TcR-CD3 complex, intracytoplasmic labelling of CD3 was 
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Fig. 4: Effect of MACS beads and column on cell proliferation. PBL were cultivated in medium alone (control) or in the 
presence of PHA (1 %) for 3 days. At the beginning of culture, cells were either incubated with beads or passed through the column, or else 
underwent both procedures. Values shown represent the means plus SD of the triplicate ; the log scale was used to enable visualization of 
control and PHA conditions. 
 
 
Fig. 5: Proliferative response to rIL2. Unstimulated (control), unseparated CD3- and CD3+ cells were cultivated in complete 
medium in the presence of 50 U/ml of rIL2 for 24 h. Values shown represent the means plus SD of the triplicate. 
 
 
MACS purification of CD3+ cells led to over 95 % purity in all experiments. However, the level of purity was 
further improved by a combination of MACS + FACS sorting, with purities higher than 99 %. In order to 
estimate whether this difference in purity could have any practical importance in our model, we compared the 
cytolytic activity displayed by T cells positively selected according to each protocol (MACS versus MACS + 
FACS). No significant difference could be found against any of the targets considered (unpublished results). This 
confirmed that the strong cytolysis of U937 and HL60 lines was actually due to T cells. 
Given the absence of clearly defined markers for all non-T cells with non-MHC-restricted cytotoxicity, negative 
selection of these cells by elimination of T lymphocytes remains the most straightforward approach to 
determining the respective participation of these subsets in the LAK phenomenon. Despite the limitations of 
negative selection of CD3- cells by MACS, combined MACS + FACS purification was always highly efficient 
and presented major advantages compared to purification with FACS alone. An important property of 
immunomagnetic selection compared to FACS is that the duration of the sorting procedure does not depend on 
the total number of cells to select. In our hands, positive selection of CD3+ T cells from a heterogeneous 
population of 200 × 106 cells did not demand more time than purification from 20 × 106 cells, while equivalent 
purity was obtained in both cases (unpublished results). 
In addition, MACS presents several advantages over other, previously described magnetic selection systems. The 
latter were designed to be used with a higher beads/cell ratio for negative selection than for positive selection. 
Consequently, both selections had to be realized separately and the reciprocal selection fraction is systematically 
lost. On the other hand, MACS enables the simultaneous performing of positive and negative selection from the 
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same heterogeneous population, since the same beads/cell ratio is used in both cases. 
In the experiments described above, we directly used positively and negatively selected cells in proliferation and 
cytolytic assays without performing the procedures usually prescribed to detach the beads from the cells in other 
immunoselection systems, i.e. 24-hour incubation (Lea et al., 1986) or addition of goat anti-mouse-Fab 
antiserum (DetachaBead Dynal, Rasmussen et al., 1992). No significant interference of MACS selection with 
cell function was observed. The magnetic beads and the passage through the separation column did not induce 
any stimulatory or inhibitory effect on the proliferative and cytolytic responses of resting as well as stimulated 
lymphocytes. The anti-CD3 mAb used for selection may have stimulatory effects, especially when sorting is 
performed at the precursor stage. However, at the effector stage, it is unlikely that any triggering effect could 
modify the cytolytic activity of lymphocytes already cultivated for several days in the presence of anti-CD3 
mAb. We showed that the proliferation of lymphocytes previously incubated with anti-CD3 mAb was unchanged 
after positive selection of T cells with anti-CD3. Furthermore, the cytolytic activity of unsorted cells was 
unmodified by incubation with beads and anti-CD3 mAb whatever the way the cells had been stimulated (i.e. 
IL2 or IL2 + anti-CD3 mAb) (unpublished data). 
To formally rule out any influence of MACS sorting on cytotoxicity, the functional study of the same subsets 
sorted by the reciprocal fashion (i.e. CD3- cells positively sorted and CD3+ T cells negatively sorted) should be 
performed. However, due to the absence of a universal marker for all activated non-T cells with cytotoxic 
activity, this approach is more complex and several antibodies have to be used during the same sorting. 
Experiments are in progress to characterize CD3- and CD3+ subsets obtained by such sorting approaches. 
In accordance with a previous report (Ochoa et al., 1989), we found that the CD3- fraction was dramatically 
enriched in cytolytic effectors against K562 and Daudi. On the other hand, cytolytic activity against U937 and 
HL60 was similar in unsorted, CD3- and CD3+ cells. Assays are currently in progress to determine whether lysis 
of U937 and HL60 by CD3+ cells is dependent on the binding of the anti-CD3 mAb by Fc receptors present on 
the target cells (mAb-redirected cytotoxicity). However, whatever the mechanism responsible, this finding 
proved that MACS purification did not inhibit the cytolytic machinery of the cells. Taken together, our results 
showed that immunomagnetic selection with MACS is a practical approach for the purification of cytolytic 
lymphocyte subsets at the effector stage. 
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